Rune Brautaset
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rune Brautaset has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Maria Nilsson
Unit of Optometry, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
11 shared publications - Abinaya Priya Venkataraman
Department of Clinical Neuroscience, Division of Eye and Vision, Unit of Optometry, Karolinska Institutet, Stockholm, Sweden
5 shared publications - Alberto Domínguez-Vicent
Unit of Optometry, Division of Eye and Vision, Department of Clinical Neuroscience, Karolinska Institute, 171 77 Stockholm, Sweden
5 shared publications - Alejandro Cerviño
Department of Optics & Optometry & Vision Sciences, University of Valencia, Burjassot, Valencia, Spain
4 shared publications - Tony Pansell
Department for Clinical Neurosciences, Eye and Vision, Karolinska Institutet, 17164 Stockholm, Sweden
4 shared publications J. A. M. Jennings
Department of Optometry and Neuroscience, University of Manchester Institute of Science and Technology, Manchester, UK
3 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 14 (1) , 159
Galectin-3 is elevated in Müller glia in human glaucomatous eyes and ocular hypertensive rat eyes and associated with phagocytosing states
Glaucoma is a leading cause of irreversible blindness worldwide, yet available treatments fail to prevent disease progression for all patients. It is characterized by a progressive dysfunction and loss of retinal ganglion cells. Neuroinflammation has been recognized as an underlying neurodegenerative mechanism of glaucoma in animal models and human post-mortem samples, and targeting neuroinflammation may provide additional means to neuroprotection. Galectin-3, a pro-inflammatory mediator encoded by the LGALS3 gene in humans, holds promise as a treatable target as its pharmacological and genetic inhibition is neuroprotective in multiple models of experimental glaucoma. However, the role of Galectin-3 in glaucoma remains unclear, particularly whether its emergence is a consequence of degeneration, or occurs at earlier time points. To address these knowledge gaps, we labeled IBA1, GFAP, and Galectin-3 in retina sections at early glaucoma stages in the rat bead glaucoma model, and in human retina from glaucoma donors. In the rat, IBA1 volume, but not GFAP, increased at an early, pre-degenerative timepoint. Accompanying this, we identified a significant increase of Galectin-3/IBA1 colocalization compared to control at the same timepoint, supporting the upregulation of Galectin-3 in early inflammation, preceding retinal ganglion cell degeneration in experimental glaucoma. However, a significant increase in Galectin-3/GFAP colocalization compared to control at the same timepoint in the rat additionally associates Galectin-3 production with astrocytes and Müller glia. This Galectin-3 to Müller glia relationship was significantly pronounced in human glaucomatous retina, predominating over microglia co-labelling. We further demonstarted that human MIO-M1 Müller glia in vitro express Galectin-3, but this is not altered in response to glaucoma relevant stimuli (TNF-α or mild-metabolic stress from rotenone). Instead, Galectin-3 expression was altered in phagocytosing states from exposure to E. coli particles, brain synaptosomes, or apoptotic neuronal debris. These findings provide further insight into Galectin-3 and gross inflammatory responses in glaucoma pathology.
- 4 August 2026
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 14 (1) , 159
Open AccessGalectin-3 is elevated in Müller glia in human glaucomatous eyes and ocular hypertensive rat eyes and associated with phagocytosing states
Glaucoma is a leading cause of irreversible blindness worldwide, yet available treatments fail to prevent disease progression for all patients. It is characterized by a progressive dysfunction and loss of retinal ganglion cells. Neuroinflammation has been recognized as an underlying neurodegenerative mechanism of glaucoma in animal models and human post-mortem samples, and targeting neuroinflammation may provide additional means to neuroprotection. Galectin-3, a pro-inflammatory mediator encoded by the LGALS3 gene in humans, holds promise as a treatable target as its pharmacological and genetic inhibition is neuroprotective in multiple models of experimental glaucoma. However, the role of Galectin-3 in glaucoma remains unclear, particularly whether its emergence is a consequence of degeneration, or occurs at earlier time points. To address these knowledge gaps, we labeled IBA1, GFAP, and Galectin-3 in retina sections at early glaucoma stages in the rat bead glaucoma model, and in human retina from glaucoma donors. In the rat, IBA1 volume, but not GFAP, increased at an early, pre-degenerative timepoint. Accompanying this, we identified a significant increase of Galectin-3/IBA1 colocalization compared to control at the same timepoint, supporting the upregulation of Galectin-3 in early inflammation, preceding retinal ganglion cell degeneration in experimental glaucoma. However, a significant increase in Galectin-3/GFAP colocalization compared to control at the same timepoint in the rat additionally associates Galectin-3 production with astrocytes and Müller glia. This Galectin-3 to Müller glia relationship was significantly pronounced in human glaucomatous retina, predominating over microglia co-labelling. We further demonstarted that human MIO-M1 Müller glia in vitro express Galectin-3, but this is not altered in response to glaucoma relevant stimuli (TNF-α or mild-metabolic stress from rotenone). Instead, Galectin-3 expression was altered in phagocytosing states from exposure to E. coli particles, brain synaptosomes, or apoptotic neuronal debris. These findings provide further insight into Galectin-3 and gross inflammatory responses in glaucoma pathology.
- Open Access
- 13 October 2025
- Published by Springer Nature in Trials
- Vol. 26 (1) , 403
Interventional Vitamin Mix Glaucoma Study (IVMGS): study protocol for a prospective, randomized, two-arm, single-center trial in existing glaucoma patients
Background: Glaucoma is a leading cause of irreversible blindness, characterized by progressive degeneration of retinal ganglion cells. Current treatments primarily lower intraocular pressure but do not directly provide neuroprotection. Preclinical studies from our group have identified dysfunction in one-carbon metabolism as a contributor to glaucomatous neurodegeneration in rodent models. The Interventional Vitamin Mix Glaucoma Study will evaluate whether 12 months of supplementation with key one-carbon metabolism cofactors and precursors (vitamins B6, B9, B12, and choline) can improve inner retinal function and provide neuroprotection compared with standard care alone. Methods: The Interventional Vitamin Mix Glaucoma Study is a Phase 2a, open-label, randomized, two-arm clinical trial. Participants will be assigned in a one-to-one ratio to receive either daily one-carbon metabolism supplementation plus standard care or standard care alone. The study will enroll 80 patients with primary open-angle glaucoma, normal tension glaucoma, or pseudoexfoliation glaucoma, each with mild-to-moderate visual field loss in at least one eye. Recruitment will take place from March 2025 to March 2026 at St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. The primary outcome is change in the photopic negative response measured by full-field electroretinography. Secondary outcomes include changes in visual field parameters, retinal nerve fiber layer thickness, and ganglion cell–inner plexiform layer thickness. Exploratory outcomes will include changes in blood-based metabolomic and DNA methylation profiles. Discussion: One-carbon metabolism–based supplementation has been shown to reduce retinal ganglion cell loss in rodent models of glaucoma. This trial will investigate whether such supplementation improves retinal function and confers neuroprotection in patients with glaucoma. The use of full-field electroretinography as the primary outcome aims to detect early functional improvements in the retina. If successful, this approach could support a low-cost, widely available neuroprotective strategy to be used alongside existing intraocular pressure–lowering therapies. Trial registration: This trial is registered at ClinicalTrials.gov (NCT06885827), first posted on 20 March 2025.
- 13 October 2025
- Published by Springer Nature in Trials
- Vol. 26 (1) , 403
Open AccessInterventional Vitamin Mix Glaucoma Study (IVMGS): study protocol for a prospective, randomized, two-arm, single-center trial in existing glaucoma patients
Background: Glaucoma is a leading cause of irreversible blindness, characterized by progressive degeneration of retinal ganglion cells. Current treatments primarily lower intraocular pressure but do not directly provide neuroprotection. Preclinical studies from our group have identified dysfunction in one-carbon metabolism as a contributor to glaucomatous neurodegeneration in rodent models. The Interventional Vitamin Mix Glaucoma Study will evaluate whether 12 months of supplementation with key one-carbon metabolism cofactors and precursors (vitamins B6, B9, B12, and choline) can improve inner retinal function and provide neuroprotection compared with standard care alone. Methods: The Interventional Vitamin Mix Glaucoma Study is a Phase 2a, open-label, randomized, two-arm clinical trial. Participants will be assigned in a one-to-one ratio to receive either daily one-carbon metabolism supplementation plus standard care or standard care alone. The study will enroll 80 patients with primary open-angle glaucoma, normal tension glaucoma, or pseudoexfoliation glaucoma, each with mild-to-moderate visual field loss in at least one eye. Recruitment will take place from March 2025 to March 2026 at St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. The primary outcome is change in the photopic negative response measured by full-field electroretinography. Secondary outcomes include changes in visual field parameters, retinal nerve fiber layer thickness, and ganglion cell–inner plexiform layer thickness. Exploratory outcomes will include changes in blood-based metabolomic and DNA methylation profiles. Discussion: One-carbon metabolism–based supplementation has been shown to reduce retinal ganglion cell loss in rodent models of glaucoma. This trial will investigate whether such supplementation improves retinal function and confers neuroprotection in patients with glaucoma. The use of full-field electroretinography as the primary outcome aims to detect early functional improvements in the retina. If successful, this approach could support a low-cost, widely available neuroprotective strategy to be used alongside existing intraocular pressure–lowering therapies. Trial registration: This trial is registered at ClinicalTrials.gov (NCT06885827), first posted on 20 March 2025.
- Open Access
- 1 May 2024
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 50 (5) , 486-491
Precision of a new SS-OCT biometer to measure anterior segment parameters and agreement with 3 instruments with different measurement principles
Purpose: To evaluate the repeatability of a new swept source optical coherence tomography (SS-OCT)–based biometer to measure anterior segment parameters and to assess the agreement with 3 other imaging devices based on different measurement principles. Setting: Unit of Eye and Vision, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. Design: Prospective, comparative case series. Methods: 3 consecutive measurements were obtained in unoperated eyes with the Eyestar900 (SS-OCT), Lenstar 900, MS-39, and Sirius. The following anterior segment parameters were evaluated: central corneal thickness (CCT), corneal diameter (CD), aqueous depth (AQD), and corneal power metrics. The repeatability limit (Rlim), coefficient of variation (CoV), and a repeated measures Bland-Altman analysis were performed. Results: 74 eyes of 74 participants were measured. The Rlims for CCT, CD, and AQD were lower than 10 μm, 0.3 mm, and 0.10 mm for all devices, respectively. The corresponding CoVs for these parameters never exceeded 1.2%. The Rlim for the corneal power metrics never exceeded 0.60 diopter (D) for any of the instruments. Lenstar showed the best agreement with the MS-39 to measure CCT, CD, and AQD (limit of agreement interval, LoA: 15.54 μm, 0.55 mm, and 0.16 mm, respectively). The mean difference for keratometry parameters was lower than 0.3 D for all device comparisons, and the LoA interval ranged between 0.52 D and 1.21 D. Conclusions: The repeatability for measuring anterior segment parameters was good, and the agreement among all the instruments was good for CD and AQD measurements. However, for CCT and keratometer parameters, the instruments cannot be used interchangeably due to large LoA interval.
- 1 May 2024
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 50 (5) , 486-491
Open AccessPrecision of a new SS-OCT biometer to measure anterior segment parameters and agreement with 3 instruments with different measurement principles
Purpose: To evaluate the repeatability of a new swept source optical coherence tomography (SS-OCT)–based biometer to measure anterior segment parameters and to assess the agreement with 3 other imaging devices based on different measurement principles. Setting: Unit of Eye and Vision, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. Design: Prospective, comparative case series. Methods: 3 consecutive measurements were obtained in unoperated eyes with the Eyestar900 (SS-OCT), Lenstar 900, MS-39, and Sirius. The following anterior segment parameters were evaluated: central corneal thickness (CCT), corneal diameter (CD), aqueous depth (AQD), and corneal power metrics. The repeatability limit (Rlim), coefficient of variation (CoV), and a repeated measures Bland-Altman analysis were performed. Results: 74 eyes of 74 participants were measured. The Rlims for CCT, CD, and AQD were lower than 10 μm, 0.3 mm, and 0.10 mm for all devices, respectively. The corresponding CoVs for these parameters never exceeded 1.2%. The Rlim for the corneal power metrics never exceeded 0.60 diopter (D) for any of the instruments. Lenstar showed the best agreement with the MS-39 to measure CCT, CD, and AQD (limit of agreement interval, LoA: 15.54 μm, 0.55 mm, and 0.16 mm, respectively). The mean difference for keratometry parameters was lower than 0.3 D for all device comparisons, and the LoA interval ranged between 0.52 D and 1.21 D. Conclusions: The repeatability for measuring anterior segment parameters was good, and the agreement among all the instruments was good for CD and AQD measurements. However, for CCT and keratometer parameters, the instruments cannot be used interchangeably due to large LoA interval.
- Open Access
- 28 July 2023
- Published by Linnaeus University in Scandinavian Journal of Optometry and Visual Science
- Vol. 16 (1) , 1–5
Refractive trends in 15-year-old adolescents at optometric practices in southern Sweden between 2007 and 2020
The purpose of this study was to analyse the distribution of refractive errors in 15-year-old adolescents at optometric practices in southern Sweden between 2007 and 2020. Refractive data were collected retrospectively from clinical records in five optometric practices in southern Sweden. The inclusion criteria were individuals visiting the practice at an age of 15 years between 2007 and 2020. The refractive errors were classified by the spherical equivalent (SE) (sphere + 1⁄2 cylinder) as follows: myopia (SE ≤ -0.5 D), hyperopia (SE ≥ 0.5 D), emmetropia (-0.5 > SE < 0.5 D). The astigmatism axis (-1.5 DC) was analysed as with-the-rule, against-the-rule and oblique according to traditional methods. To examine trends, the average refraction and distribution of refractive errors were compared between two selected time periods, 2007–2013 and 2014–2020. During the time frame 500 adolescents aged 15 years were examined in the selected optometric practices. Myopia was found in 34%, emmetropia in 35% and hyperopia in 31%. Among 37 individuals with astigmatism, the most common axis was with- the-rule (41%), followed by oblique (32%) and against-the-rule (27%). No significant differences could be found in the distribution of different refractive errors between the periods 2007–2013 and 2014–2020. Nor could any significant difference in average refraction be found. In contrast to the expected global rise in myopia as predicted by WHO and the high prevalence of myopia reported in some parts of the world, we could not find convincing changes in distribution between myopia and hyperopia in this cohort of Swedish adolescents.
- 28 July 2023
- Published by Linnaeus University in Scandinavian Journal of Optometry and Visual Science
- Vol. 16 (1) , 1–5
Open AccessRefractive trends in 15-year-old adolescents at optometric practices in southern Sweden between 2007 and 2020
The purpose of this study was to analyse the distribution of refractive errors in 15-year-old adolescents at optometric practices in southern Sweden between 2007 and 2020. Refractive data were collected retrospectively from clinical records in five optometric practices in southern Sweden. The inclusion criteria were individuals visiting the practice at an age of 15 years between 2007 and 2020. The refractive errors were classified by the spherical equivalent (SE) (sphere + 1⁄2 cylinder) as follows: myopia (SE ≤ -0.5 D), hyperopia (SE ≥ 0.5 D), emmetropia (-0.5 > SE < 0.5 D). The astigmatism axis (-1.5 DC) was analysed as with-the-rule, against-the-rule and oblique according to traditional methods. To examine trends, the average refraction and distribution of refractive errors were compared between two selected time periods, 2007–2013 and 2014–2020. During the time frame 500 adolescents aged 15 years were examined in the selected optometric practices. Myopia was found in 34%, emmetropia in 35% and hyperopia in 31%. Among 37 individuals with astigmatism, the most common axis was with- the-rule (41%), followed by oblique (32%) and against-the-rule (27%). No significant differences could be found in the distribution of different refractive errors between the periods 2007–2013 and 2014–2020. Nor could any significant difference in average refraction be found. In contrast to the expected global rise in myopia as predicted by WHO and the high prevalence of myopia reported in some parts of the world, we could not find convincing changes in distribution between myopia and hyperopia in this cohort of Swedish adolescents.
- Top Cited PapersOpen Access
- 1 July 2021
- Published by Elsevier in Redox Biology
- Vol. 43, 101988
Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
- 1 July 2021
- Published by Elsevier in Redox Biology
- Vol. 43, 101988
Top Cited PapersOpen AccessNicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
- Open Access
- 29 January 2021
- Published by MDPI AG in Applied Sciences
- Vol. 11 (3) , 1250
Evaluation of Automated Segmentation Algorithm for Macular Volumetric Measurements of Eight Individual Retinal Layer Thickness
Background: We evaluated the performance of an automated algorithm available on a clinical OCT (Canon-HS100) for macular volumetric measurements of eight individual retinal layers. Methods and Analysis: Two consecutive three-dimensional scans were acquired on 29 subjects with healthy retinas. Thickness measurements were obtained from eight individual retinal layers in nine macular sectors based on Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. The repeatability was evaluated using the within-subject standard deviation from which the repeatability limits (Rlimit) and coefficient of variation (CoV) were calculated. Results: The repeatability metrics varied among different layers and sectors. The variation among the sectors was larger in two of the outer layers (plexiform and nuclear layer) and the retinal nerve fiber layer. For the other five layers, the repeatability limit was less than 5µm and CoV was less than 7.5% in all nine ETDRS sectors. Conclusions: The repeatability of the OCT-HS100 to measure eight individual retinal layers is good in general. Nevertheless, the repeatability is not homogeneous among different layers and sectors. This needs to be taken into account while designing clinical measurement protocols.
- 29 January 2021
- Published by MDPI AG in Applied Sciences
- Vol. 11 (3) , 1250
Open AccessEvaluation of Automated Segmentation Algorithm for Macular Volumetric Measurements of Eight Individual Retinal Layer Thickness
Background: We evaluated the performance of an automated algorithm available on a clinical OCT (Canon-HS100) for macular volumetric measurements of eight individual retinal layers. Methods and Analysis: Two consecutive three-dimensional scans were acquired on 29 subjects with healthy retinas. Thickness measurements were obtained from eight individual retinal layers in nine macular sectors based on Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. The repeatability was evaluated using the within-subject standard deviation from which the repeatability limits (Rlimit) and coefficient of variation (CoV) were calculated. Results: The repeatability metrics varied among different layers and sectors. The variation among the sectors was larger in two of the outer layers (plexiform and nuclear layer) and the retinal nerve fiber layer. For the other five layers, the repeatability limit was less than 5µm and CoV was less than 7.5% in all nine ETDRS sectors. Conclusions: The repeatability of the OCT-HS100 to measure eight individual retinal layers is good in general. Nevertheless, the repeatability is not homogeneous among different layers and sectors. This needs to be taken into account while designing clinical measurement protocols.
- Open Access
- 29 September 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (10) , 3144
Evaluation of the Performance of Algorithm-Based Methods for Subjective Refraction
Objective: To evaluate the performance of two subjective refraction measurement algorithms by comparing the refraction values, visual acuity, and the time taken by the algorithms with the standard subjective refraction (SSR). Methods: The SSR and two semi-automated algorithm-based subjective refraction (SR1 and SR2) in-built in the Vision-R 800 phoropter were performed in 68 subjects. In SR1 and SR2, the subject’s responses were recorded in the algorithm which continuously modified the spherical and cylindrical component accordingly. The main difference between SR1 and SR2 is the use of an initial fogging step in SR1. Results: The average difference and agreement limits intervals in the spherical equivalent between each refraction method were smaller than 0.25 D, and 2.00 D, respectively. For the cylindrical components, the average difference was almost zero and the agreement limits interval was less than 0.50 D. The visual acuities were not significantly different among the methods. The times taken for SR1 and SR2 were significantly shorter, and SR2 was on average was three times faster than SSR. Conclusions: The refraction values and the visual acuity obtained with the standard subjective refraction and algorithm-based methods were similar on average. The algorithm-based methods were significantly faster than the standard method.
- 29 September 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (10) , 3144
Open AccessEvaluation of the Performance of Algorithm-Based Methods for Subjective Refraction
Objective: To evaluate the performance of two subjective refraction measurement algorithms by comparing the refraction values, visual acuity, and the time taken by the algorithms with the standard subjective refraction (SSR). Methods: The SSR and two semi-automated algorithm-based subjective refraction (SR1 and SR2) in-built in the Vision-R 800 phoropter were performed in 68 subjects. In SR1 and SR2, the subject’s responses were recorded in the algorithm which continuously modified the spherical and cylindrical component accordingly. The main difference between SR1 and SR2 is the use of an initial fogging step in SR1. Results: The average difference and agreement limits intervals in the spherical equivalent between each refraction method were smaller than 0.25 D, and 2.00 D, respectively. For the cylindrical components, the average difference was almost zero and the agreement limits interval was less than 0.50 D. The visual acuities were not significantly different among the methods. The times taken for SR1 and SR2 were significantly shorter, and SR2 was on average was three times faster than SSR. Conclusions: The refraction values and the visual acuity obtained with the standard subjective refraction and algorithm-based methods were similar on average. The algorithm-based methods were significantly faster than the standard method.
- Open Access
- 23 September 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (10) , 3061
Effect of Instrument Design and Technique on the Precision and Accuracy of Objective Refraction Measurement
Background: To evaluate the precision and accuracy of objective refraction measurement obtained with combinations of instrument design and technique. We also compared the performance of the instruments with subjective refraction measurements. Method and analysis: The objective refraction was measured in 71 subjects with three autorefractometers that have different designs and measurement principles (binocular with fogging, binocular without fogging, and monocular with fogging). Repeatability and reproducibility metrics were calculated for the objective refraction measurements. The agreement of the objective refraction measurements between the three instruments and the agreement with the subjective refraction measurements were evaluated. Results: All three autorefractometers had repeatability and reproducibility limits smaller than 0.70D. The smallest difference (0.10D) in the spherical equivalent was seen between the two binocular instruments. Compared with the subjective refraction, the binocular without fogging technique had the smallest mean difference in spherical equivalent (<0.20D) whereas the binocular fogging technique had the smallest limit of agreement interval (1.00D). For all comparisons, the mean difference and limit of agreement interval for the cylindrical components were lower than 0.10D and 0.75D, respectively. Conclusion: All three instruments evaluated had good repeatability and reproducibility. The binocular fogging technique provided the best agreement with subjective refraction.
- 23 September 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (10) , 3061
Open AccessEffect of Instrument Design and Technique on the Precision and Accuracy of Objective Refraction Measurement
Background: To evaluate the precision and accuracy of objective refraction measurement obtained with combinations of instrument design and technique. We also compared the performance of the instruments with subjective refraction measurements. Method and analysis: The objective refraction was measured in 71 subjects with three autorefractometers that have different designs and measurement principles (binocular with fogging, binocular without fogging, and monocular with fogging). Repeatability and reproducibility metrics were calculated for the objective refraction measurements. The agreement of the objective refraction measurements between the three instruments and the agreement with the subjective refraction measurements were evaluated. Results: All three autorefractometers had repeatability and reproducibility limits smaller than 0.70D. The smallest difference (0.10D) in the spherical equivalent was seen between the two binocular instruments. Compared with the subjective refraction, the binocular without fogging technique had the smallest mean difference in spherical equivalent (<0.20D) whereas the binocular fogging technique had the smallest limit of agreement interval (1.00D). For all comparisons, the mean difference and limit of agreement interval for the cylindrical components were lower than 0.10D and 0.75D, respectively. Conclusion: All three instruments evaluated had good repeatability and reproducibility. The binocular fogging technique provided the best agreement with subjective refraction.
- 5 August 2018
- Published by Springer Nature
- p. 180-189
Visual Ergonomics in Control Room Environments: A Case Study from a Swedish Paper Mill
- 5 August 2018
- Published by Springer Nature
- p. 180-189
Visual Ergonomics in Control Room Environments: A Case Study from a Swedish Paper Mill
- Open Access
- 11 February 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (2) , e0149138
Repeatability Using Automatic Tracing with Canon OCT- HS100 and Zeiss Cirrus HD-OCT 5000
Optical coherence tomography (OCT), can be used in clinical practice to provide high resolution cross-sectional images of the retina, optic disc and macula structure. These measurements can be useful for early detection, diagnosis, monitoring and treatment guidance for retinal diseases. Therefore, repeatability of measurements in OCT is of great importance. Macula and optic disc parameters from the right eye of 30 healthy subjects were obtained twice with the Canon OCT-HS100 and Zeiss Cirrus HD-OCT 5000. Repeatability was evaluated by use of the coefficient of repeatability (CR) and the coefficient of repeatability as a percentage of the mean (CR%), and the obtained measurements were compared between the instruments. CR% of optic disc parameters ranged between 0.90 and 22.22% and 0.00 and 16.00% with the Canon and Zeiss OCT respectively. For macular parameters CR% ranged between 0.62 and 2.81% and 0.99 and 1.81% with the Canon and Zeiss OCT respectively. No statistical difference could be found when comparing the CR of all macular and disc measurements between the instruments. Compared to our previously published data repeatability has significantly improved with the inclusion of automatic tracking systems with both the Canon and Zeiss OCT. Automatic tracking function improves repeatability in both Canon OCT-HS100 and Zeiss Cirrus HD-OCT 5000. However, measurements generated by the two instruments are still not interchangeable.
- 11 February 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (2) , e0149138
Open AccessRepeatability Using Automatic Tracing with Canon OCT- HS100 and Zeiss Cirrus HD-OCT 5000
Optical coherence tomography (OCT), can be used in clinical practice to provide high resolution cross-sectional images of the retina, optic disc and macula structure. These measurements can be useful for early detection, diagnosis, monitoring and treatment guidance for retinal diseases. Therefore, repeatability of measurements in OCT is of great importance. Macula and optic disc parameters from the right eye of 30 healthy subjects were obtained twice with the Canon OCT-HS100 and Zeiss Cirrus HD-OCT 5000. Repeatability was evaluated by use of the coefficient of repeatability (CR) and the coefficient of repeatability as a percentage of the mean (CR%), and the obtained measurements were compared between the instruments. CR% of optic disc parameters ranged between 0.90 and 22.22% and 0.00 and 16.00% with the Canon and Zeiss OCT respectively. For macular parameters CR% ranged between 0.62 and 2.81% and 0.99 and 1.81% with the Canon and Zeiss OCT respectively. No statistical difference could be found when comparing the CR of all macular and disc measurements between the instruments. Compared to our previously published data repeatability has significantly improved with the inclusion of automatic tracking systems with both the Canon and Zeiss OCT. Automatic tracking function improves repeatability in both Canon OCT-HS100 and Zeiss Cirrus HD-OCT 5000. However, measurements generated by the two instruments are still not interchangeable.